FHA
RETA

Flagship Harbor Advisors’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Flagship Harbor Advisors’s Portfolio RETA Stock Details RETA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-94
Closed -$9K – 1890
2020
Q3 		$9K Hold
94
– – ﹤0.01% 1376
2020
Q2 		$14K Hold
94
– – ﹤0.01% 1258
2020
Q1 		$14K Hold
94
– – ﹤0.01% 1145
2019
Q4 		$19K Buy
94
+24
+34% +$4.38K ﹤0.01% 1134
2019
Q3 		$5K Hold
70
– – ﹤0.01% 1518
2019
Q2 		$6K Buy
+70
New +$6.04K ﹤0.01% 1471

Other funds holding RETA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DFO
Duquesne Family Office New York $2.94B AUM 61.92% 1-Year Est. Return
CA
Corriente Advisors Fort Worth, Texas $3.45M AUM
CAM
Cormorant Asset Management Boston, Massachusetts $1.98B AUM 737.95% 1-Year Est. Return